Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy (Q39517953)

scientific article published on 15 June 2011

Language	Label	Description	Also known as
English	Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy	scientific article published on 15 June 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

12 September 2017

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

stated in

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy (English)

1 reference

stated in

Europe PubMed Central

12 September 2017

1 reference

Priyambada Parhi

1

1 reference

stated in

Europe PubMed Central

PubMed ID

21704741

retrieved

12 September 2017

Chandana Mohanty

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

21704741

retrieved

12 September 2017

Sanjeeb Kumar Sahoo

series ordinal

3

1 reference

stated in

Europe PubMed Central

12 September 2017

15 June 2011

1 reference

stated in

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

7

1 reference

stated in

Europe PubMed Central

12 September 2017

3656-3669

1 reference

stated in

Europe PubMed Central

12 September 2017

10

1 reference

stated in

Europe PubMed Central

12 September 2017

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2010.08.010

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2010.02.010

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Caspase independent/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Solubilization of rapamycin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Rapamycin promotes beta-amyloid production via ADAM-10 inhibition

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The emerging nanomedicine landscape

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Pluronic block copolymers: novel functional molecules for gene therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

mTOR and cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

When translation meets transformation: the mTOR story

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Nanotech approaches to drug delivery and imaging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Mitochondria and apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Multifunctional Gold Nanoparticle−Peptide Complexes for Nuclear Targeting

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

A novel nanoparticle formulation for sustained paclitaxel delivery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Distribution of sirolimus in rat tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Ligand-based targeted therapy for cancer tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

A novel in situ gel for sustained drug delivery and targeting

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Protein nanoparticles as drug carriers in clinical medicine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The TOR pathway: a target for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The present and future of nanotechnology in human health care

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy.

2 references

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1021/AM101196V

Nanoparticle agglutination: acceleration of aggregation rates and broadening of the analyte concentration range using mixtures of various-sized nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2011.06.015

Identifiers

DOI

10.1016/J.ACTBIO.2011.06.015

1 reference

stated in

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

PubMed ID

21704741

retrieved

12 September 2017

ResearchGate publication ID

51249374

0 references

Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy (Q39517953)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy (Q39517953)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search